↓ Skip to main content

Dove Medical Press

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, June 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
f1000
1 research highlight platform

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
49 Mendeley